We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.14 | 6.91% | 2.165 | 2.05 | 2.28 | 2.29 | 1.995 | 2.00 | 4,381,830 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2019 13:19 | Oh dear yet another bull trap.....was this Tim's idea | kop202 | |
22/2/2019 12:07 | Lemmings and mushrooms only. Just a lifestyle company now for the managers until the cash runs out. | ken chung | |
22/2/2019 10:38 | I still have some of these at 50, since bought 12 sold 17 no follow through news, I may be wrong but this has a habit of promising everything and delivering little,moved to trading (HAYD), was a good buy 2.3p I will retain my 50p holding see if anything happens going forward, still be big question about the £10M 144p placing months before Phase 3 failure, still its pays the board to keep the story going, this is AIM after all. No not trying to buy lower. Time for the Company to deliver some rock solid news though. | ny boy | |
22/2/2019 09:22 | Many ved nicely above the 200ema. Should see this push on later. | letmepass | |
22/2/2019 09:07 | Hope they took their own advice then xD | a_2_b | |
22/2/2019 09:07 | Should finish over 20p today | letmepass | |
22/2/2019 09:04 | Large buy orders all over level 2 | kirk 6 | |
22/2/2019 09:00 | Sellers gone and up we go. Should be a good push for the next few weeks. | letmepass | |
22/2/2019 08:50 | guess who ? 21 Feb '19 - 09:33 - 33924 of 33955 0 0 1 Buy those dips here 20p+ coming imo | arab3 | |
22/2/2019 08:41 | Exactly he had many chances in the past and is a little regretful now lmao | a_2_b | |
22/2/2019 08:39 | You should have seen his posts on CHAL. He is just trying to get in lower. No doubt sold at a loss | letmepass | |
22/2/2019 08:38 | after all his ramping posts last year you think he would know the answers | arab3 | |
22/2/2019 08:37 | News coming. Natural adjustment to remove the weak. This moves quickly if good news comes | letmepass | |
22/2/2019 08:36 | Do some research NY boy. | letmepass | |
22/2/2019 08:32 | Quite a lot of selling today. Are we on our way down? | herb clark | |
22/2/2019 08:31 | You do wonder how much of that £10M they have left (13 months ago now), they conveniently got away @ 144p, months before the share price collapse! Cash burn anyone? | ny boy | |
21/2/2019 23:28 | Lupuzor(TM) Extension Study The Lupuzor(TM) open label extension study is progressing as planned, with a total of 62 eligible patients from the original Phase III trial recruited throughout the US and Europe. This study remains on track to report results in Q2 2019. | ny boy | |
21/2/2019 23:23 | Some boys are never happy, that is why they have never grown UP. Some they say: They could be suffering from Peter Pan Syndrome | master rsi | |
21/2/2019 22:19 | Why don't you do one of two things, either put up or shut up. Simple | brad44 | |
21/2/2019 21:31 | NY boy.. Go back to ramping CHAL | letmepass | |
21/2/2019 20:36 | Wonder how much cash they have left, could be a pump up to get a placing away, never know with this outfit, after the big disappointment last April. Otherwise maybe investors taking a punt that news could be due before end of Q1 | ny boy | |
21/2/2019 19:31 | All the best D hoping you make it back and extra | a_2_b | |
21/2/2019 18:53 | Perfectly stated David | catch007 | |
21/2/2019 18:46 | Thanks Dave ? | kirk 6 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions